Paradox of B cell-targeted therapies

Journal of Clinical Investigation

Volumn 118, Issue 10, 2008, Pages 3260-3263

  Kurosaki, Tomohiro ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b Institute of Physical and Chemical Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD1D ANTIGEN; CD20 ANTIBODY; CD5 ANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CELL THERAPY; DISEASE COURSE; NONHUMAN; NOTE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD20; B-LYMPHOCYTES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNOTHERAPY; MICE; MICE, KNOCKOUT; MULTIPLE SCLEROSIS;

EID: 55849126739     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI37099     Document Type: Note

References (23)

1. Ravetch, J.V. 2003. Fc receptors. In Fundamental immunology. W.E. Paul, editor. Lippincott Williams & Wilkins. Philadelphia, Pennsylvania, USA. 685-700.
2. Martin, F., and Chan, A.C. 2006. B cell immunobiology in disease: evolving concepts from the clinic. Annu. Rev. Immunol. 24:467-496.
3. Shlomchik, M.J., Madaio, M.P., Ni, D., Trounstein, M., and Huszar, D. 1994. The role of B cells in lpr/lpr-induced autoimmunity. J. Exp. Med. 180:1295-1306.
4. Chan, O.T., Hannum, L.G., Haberman, A.M., Madaio, M.P., and Shlomchik, M.J. 1999. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189:1639-1648.
5. Wolf, S.D., Dittel, B.N., Hardardottir, F., and Janeway, C.A., Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184:2271-2278.
6. Hauser, S.L., et al. 2008. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358:676-688.
7. Matsushita, T., Yanaba, K., Bouaziz, J.-D., Fujimoto, M., and Tedder, T.F. 2008. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118:3420-3430.
8. El Behi, M., et al. 2005. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Lett. 96:11-26.
9. O'Garra, A., et al. 1990. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int. Immunol. 2:821-832.
10. Amano, M., et al. 1998. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: beta 2-microglobulin-dependent and independent forms. J. Immunol. 161:1710-1717.
11. Yanaba, K., et al. 2008. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 28:639-650.
12. Wang, B., et al. 2000. CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J. Immunol. 165:6783-6790.
13. Fillatreau, S., Sweenie, C.H., McGeachy, M.J., Gray, D., and Anderton, S.M. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3:944-950.
14. Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R.S., and Bhan, A.K. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity. 16:219-230.
15. Mauri, C., Gray, D., Mushtaq, N., and Londei, M. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197:489-501.
16. Duddy, M.E., Alter, A., and Bar-Or, A. 2004. Distinct profiles of human B cell effector cytokines: a role in immune regulation? J. Immunol. 172:3422-3427.
17. Duddy, M., et al. 2007. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J. Immunol. 178:6092-6099.
18. Moulin, V., et al. 2000. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J. Exp. Med. 192:475-482.
19. Lampropoulou, V., et al. 2008. TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 180:4763-4773.
20. Mann, M.K., Maresz, K., Shriver, L.P., Tan, Y., and Dittel, B.N. 2007. B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J. Immunol. 178:3447-3456.
21. Abdul-Majid, K.B., et al. 2002. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scand. J. Immunol. 55:70-81.
22. Lyons, J.A., Ramsbottom, M.J., and Cross, A.H. 2002. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur. J. Immunol. 32:1905-1913.
23. Goetz, M., Atreya, R., Ghalibafian, M., Galle, P.R., and Neurath, M.F. 2007. Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm. Bowel Dis. 13:1365-1368.